May 13, 2020 / 10:07 PM / 13 days ago

BRIEF-MacroGenics Announces Preliminary Clinical Results From MGD013 And MGC018 To Be Presented At ASCO Annual Meeting

May 13 (Reuters) - MacroGenics Inc:

* MACROGENICS ANNOUNCES PRELIMINARY CLINICAL RESULTS FROM MGD013 AND MGC018 TO BE PRESENTED AT THE ASCO ANNUAL MEETING

* MACROGENICS INC - SAFETY PROFILE OF MGC018, WHICH INCLUDES HEMATOLOGIC AND SKIN TOXICITIES, HAS BEEN GENERALLY MANAGEABLE TO DATE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below